Ignite Creation Date:
2024-05-06 @ 1:59 AM
Last Modification Date:
2024-10-26 @ 11:12 AM
Study NCT ID:
NCT01943864
Status:
COMPLETED
Last Update Posted:
2017-05-31
First Post:
2013-09-12
Brief Title:
A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
117134
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None